CLINICAL_TRIALS
trial_result
· 2018-10-24
Clinical Trial Update: Neuromuscular Blockade Reversal Agent Effect on Postoperative Cognitive Function and Behaviour in Children [Phase 4]
Summary
A Phase 4 clinical trial evaluating a neuromuscular blockade reversal agent and its effects on postoperative cognitive function and behavior in children has com…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Attikon Hospital | Conditions: Anesthesia; Functional | Phase 4 | Status: COMPLETED